Abstract

Many of the actions of growth hormone (GH) on somatic growth and tissue maintenance are mediated by insulin-like growth factor-I (IGF-I), a secreted protein whose gene expression is rapidly and potently induced by GH by unknown mechanisms. Recent studies implicating Stat5a and Stat5b in the growth response to GH in mice and observations linking Stat5b to control of IGF-I gene transcription in rats have prompted the current investigations into the molecular determinants of a putative regulatory network extending from GH through Stat5b to IGF-I. Here we characterize as critical components of this hormone-activated transcriptional pathway two adjacent Stat5 binding sites in the second intron of the rat IGF-I gene located within a conserved region previously found to undergo acute and reversible changes in chromatin structure after in vivo GH treatment. As assessed by chromatin immunoprecipitation assays, GH rapidly induced binding of Stat5 to this DNA segment in the liver of GH-deficient rats, just prior to the onset of transcription from both major and minor IGF-I gene promoters. Biochemical reconstitution experiments showed that the two intronic Stat5 DNA elements were able to bind Stat5b in vitro after GH treatment could transmit GH- and Stat5b-dependent transcriptional responsiveness to the major IGF-I promoter and to a minimal neutral gene promoter and were required for full stimulation of reporter gene activity by GH. Taken together, these results identify an intronic enhancer as a key mediator of GH-induced IGF-I gene transcription working through Stat5b and provide new insight into the molecular architecture of this transcriptional pathway.

Highlights

  • Many of the actions of growth hormone (GH) on somatic growth and tissue maintenance are mediated by insulin-like growth factor-I (IGF-I), a secreted protein whose gene expression is rapidly and potently induced by GH by unknown mechanisms

  • We characterize as critical components of this hormone-activated transcriptional pathway two adjacent Stat5 binding sites in the second intron of the rat IGF-I gene located within a conserved region previously found to undergo acute and reversible changes in chromatin structure after in vivo GH treatment

  • Identification of a GH-regulated Stat5 Binding Site within the Rat IGF-I Gene—In past studies, we mapped a GH-stimulated DNase I-hypersensitive site termed HS7 to the second intron of the rat IGF-I gene and demonstrated that alterations in this chromosomal region coincided with GH-stimulated induction of IGF-I gene transcription in vivo [12]

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials—Antibodies to Stat (C17X) were from Santa Cruz Biotechnology (Santa Cruz, CA), and antibodies to anti-FLAG (M2) were from Sigma. Recombinant rat GH was from the National Hormone and Pituitary Program, NIDDK, National Institutes of Health. Oligonucleotides were synthesized at the Oregon Health & Sciences University Core Facility. Transit-LT1 was purchased from Mirus (Madision, WI), protein A-agarose beads were from Sigma, and the Qiaquick PCR DNA purification kit was from Qiagen (Valencia, CA). All of the other chemicals were reagent grade and were obtained from commercial suppliers. Recombinant Plasmids—A plasmid in pGL2 has been described encoding 1711 bp of rat IGF-I promoter 1 and the first 328 bp of exon 1 [18]. An 825-bp fragment of rat IGF-I intron 2 was added 5Ј to the promoter by standard molecular cloning methods.

DNA sequence
TABLE II Primers used for PCR in ChIP assays
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call